These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32323554)

  • 1. Interplay Between Oxidative Stress, Cyclooxygenases, and Prostanoids in Cardiovascular Diseases.
    Zhao S; Cheng CK; Zhang CL; Huang Y
    Antioxid Redox Signal; 2021 Apr; 34(10):784-799. PubMed ID: 32323554
    [No Abstract]   [Full Text] [Related]  

  • 2. Druggable Prostanoid Pathway.
    Mazaleuskaya LL; Ricciotti E
    Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases.
    Alfranca A; Iñiguez MA; Fresno M; Redondo JM
    Cardiovasc Res; 2006 Jun; 70(3):446-56. PubMed ID: 16458868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight.
    Parente L; Perretti M
    Biochem Pharmacol; 2003 Jan; 65(2):153-9. PubMed ID: 12504791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin among prostanoids.
    Gryglewski RJ
    Pharmacol Rep; 2008; 60(1):3-11. PubMed ID: 18276980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin inhibition and cardiovascular risk: maybe timing really is everything.
    Bertagnolli MM; Zauber AG; Solomon S
    Cancer Prev Res (Phila); 2009 Mar; 2(3):195-6. PubMed ID: 19258547
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
    Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
    Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension.
    Tang EH; Vanhoutte PM
    Physiol Genomics; 2008 Feb; 32(3):409-18. PubMed ID: 18056786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-mediated endothelium-dependent contractions: from the past to recent discoveries.
    Wong MS; Vanhoutte PM
    Acta Pharmacol Sin; 2010 Sep; 31(9):1095-102. PubMed ID: 20711228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid function and cardiovascular disease.
    Iñiguez MA; Cacheiro-Llaguno C; Cuesta N; Díaz-Muñoz MD; Fresno M
    Arch Physiol Biochem; 2008 Jul; 114(3):201-9. PubMed ID: 18629685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
    Capra V; Bäck M; Barbieri SS; Camera M; Tremoli E; Rovati GE
    Med Res Rev; 2013 Mar; 33(2):364-438. PubMed ID: 22434418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
    Baber SR; Champion HC; Bivalacqua TJ; Hyman AL; Kadowitz PJ
    Circulation; 2003 Aug; 108(7):896-901. PubMed ID: 12900348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases.
    Taleb A; Ahmad KA; Ihsan AU; Qu J; Lin N; Hezam K; Koju N; Hui L; Qilong D
    Biomed Pharmacother; 2018 Jun; 102():689-698. PubMed ID: 29604588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
    Longo WE; Panesar N; Mazuski JE; Kaminski D
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):77-85. PubMed ID: 10328326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Biology of Prostanoids and Drug Discovery.
    Zhu L; Zhang Y; Guo Z; Wang M
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1454-1463. PubMed ID: 32295420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.
    Cipollone F; Cicolini G; Bucci M
    Pharmacol Ther; 2008 May; 118(2):161-80. PubMed ID: 18420277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
    Ohara M; Sawa T
    Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention.
    Cathcart MC; O'Byrne KJ; Reynolds JV; O'Sullivan J; Pidgeon GP
    Biochim Biophys Acta; 2012 Jan; 1825(1):49-63. PubMed ID: 22015819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenases, prostanoids, and tumor progression.
    Wang MT; Honn KV; Nie D
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):525-34. PubMed ID: 17763971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.